Compare INLX & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INLX | CTSO |
|---|---|---|
| Founded | 1996 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.7M | 23.9M |
| IPO Year | 2013 | 2008 |
| Metric | INLX | CTSO |
|---|---|---|
| Price | $5.14 | $0.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 3.9K | ★ 349.5K |
| Earning Date | 05-14-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.79 |
| EPS | N/A | ★ N/A |
| Revenue | $11,336.00 | ★ $22,503,908.00 |
| Revenue This Year | $16.86 | $10.34 |
| Revenue Next Year | N/A | $22.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 48.53 |
| 52 Week Low | $5.05 | $0.30 |
| 52 Week High | $12.48 | $1.04 |
| Indicator | INLX | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 47.37 |
| Support Level | N/A | $0.30 |
| Resistance Level | $5.88 | $0.40 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 10.84 | 29.35 |
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.